期刊
JOURNAL OF MEMBRANE SCIENCE
卷 654, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.memsci.2022.120571
关键词
Electro centrifugal spinning; Core-sheath nanofibers; Bio-based polymer; Controlled drug release
Co-axial electro-centrifugal spinning (ECS) technology enables the large-scale production of core-sheath nanofibers and solves the nozzle clogging issue, making it applicable for controlled drug release.
Core-sheath nanofibers are a premium material to be used in the field of controlled drug release, however, a mass-production of this kind of fibers by current spinning methods is until now limited due to the issues of nozzle clogging and high costs. In this context, a brand-new technology, named co-axial electro-centrifugal spinning (ECS), which combines the technologies of co-axial electrospinning and centrifugal spinning, was proposed to fabricate core-sheath nanofibers in large amounts. Compared with traditional co-axial electrospinning, the inhouse-built co-axial ECS well addressed the nozzle cleaning problem. By means of the co-axial ECS, different kinds of core-sheath nanofibers were successfully produced. Being already extensively-applied biodegradable polymers, poly(vinyl alcohol) (PVA) and poly(L-lactic acid) (PLLA) were chosen to manufacture PVA/PLLA core/ sheath nanofibers with different core-to-sheath ratios in ultra-high production rate. Also, Paclitaxel drug was loaded in the PVA core component and its release was efficiently controlled thanks to the thickness and crystallinity of the PLA sheath. The in vitro drug release mechanism studied here suggested that the drug can still release out without the existence of porous microchannels. This accessible and low-cost technology may definitely offer a new insight into the fabrication of core-sheath nanofibers, allowing more researchers to tailor functional fabrics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据